Literature DB >> 25806322

Recent advances in the development of mutant-selective EGFR inhibitors for non-small cell lung cancer patients with EGFR-TKI resistance.

Yung-Hung Luo1, Yuh-Min Chen1.   

Abstract

Entities:  

Year:  2014        PMID： 25806322      PMCID： PMC4367682          DOI： 10.3978/j.issn.2218-6751.2014.09.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  2 in total

Review 1.  Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer.

Authors:  Yuh-Min Chen
Journal:  J Chin Med Assoc       Date:  2013-03-22       Impact factor: 2.743

Review 2.  Re-Treatment with EGFR-TKIs in NSCLC Patients Who Developed Acquired Resistance.

Authors:  Wen-Shuo Wu; Yuh-Min Chen
Journal:  J Pers Med       Date:  2014-06-25
  2 in total
  1 in total

Review 1.  Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer.

Authors:  Simon Vyse; Paul H Huang
Journal:  Signal Transduct Target Ther       Date:  2019-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.